Anderson JJ - Search Results

1

The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials.

Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, Furst D, Goldsmith C, Kieszak S, Lightfoot R, et al. Felson DT, et al. Among authors: anderson jj. Arthritis Rheum. 1993 Jun;36(6):729-40. doi: 10.1002/art.1780360601. Arthritis Rheum. 1993. PMID: 8507213

2

Comparison of rheumatoid arthritis clinical trial outcome measures: a simulation study.

Anderson JJ, Bolognese JA, Felson DT. Anderson JJ, et al. Arthritis Rheum. 2003 Nov;48(11):3031-8. doi: 10.1002/art.11293. Arthritis Rheum. 2003. PMID: 14613263 Free article.

3

The efficacy and toxicity of combination therapy in rheumatoid arthritis. A meta-analysis.

Felson DT, Anderson JJ, Meenan RF. Felson DT, et al. Among authors: anderson jj. Arthritis Rheum. 1994 Oct;37(10):1487-91. doi: 10.1002/art.1780371012. Arthritis Rheum. 1994. PMID: 7945474

4

Sensitivity to change of rheumatoid arthritis clinical trial outcome measures.

Anderson JJ, Chernoff MC. Anderson JJ, et al. J Rheumatol. 1993 Mar;20(3):535-7. J Rheumatol. 1993. PMID: 8478866

5

Problems and suggested solutions in creating an archive of clinical trials data to permit later meta-analysis: an example of methotrexate trials in rheumatoid arthritis.

Chernoff MC, Wang M, Anderson JJ, Felson DT. Chernoff MC, et al. Among authors: anderson jj. Control Clin Trials. 1995 Oct;16(5):342-55. doi: 10.1016/0197-2456(95)00049-6. Control Clin Trials. 1995. PMID: 8582152 Free article. Clinical Trial.

6

Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent?

Felson DT, Anderson JJ, Lange ML, Wells G, LaValley MP. Felson DT, et al. Among authors: anderson jj. Arthritis Rheum. 1998 Sep;41(9):1564-70. doi: 10.1002/1529-0131(199809)41:9<1564::AID-ART6>3.0.CO;2-M. Arthritis Rheum. 1998. PMID: 9751088

7

Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration.

Anderson JJ, Wells G, Verhoeven AC, Felson DT. Anderson JJ, et al. Arthritis Rheum. 2000 Jan;43(1):22-9. doi: 10.1002/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9. Arthritis Rheum. 2000. PMID: 10643696 Free article.

8

A review of evidence on the discriminant validity of outcome measures in rheumatoid arthritis.

Felson DT, Anderson JJ. Felson DT, et al. Among authors: anderson jj. J Rheumatol. 2001 Feb;28(2):422-6. J Rheumatol. 2001. PMID: 11246690 Review.

9

Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis.

Anderson JJ, Baron G, van der Heijde D, Felson DT, Dougados M. Anderson JJ, et al. Arthritis Rheum. 2001 Aug;44(8):1876-86. doi: 10.1002/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F. Arthritis Rheum. 2001. PMID: 11508441 Free article.

10

Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A metaanalysis of published clinical trials.

Felson DT, Anderson JJ, Meenan RF. Felson DT, et al. Among authors: anderson jj. Arthritis Rheum. 1992 Oct;35(10):1117-25. doi: 10.1002/art.1780351003. Arthritis Rheum. 1992. PMID: 1358078

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

389 results

Search Page

Filters